Chapter 19 Role of Wnt Signaling in the Development of Type 2 Diabetes

Vitamins and Hormones

Volumn 80, Issue C, 2009, Pages 563-581

  Bordonaro, Michael ^a  

^a Janet Weis Children s Hospital   (United States)

Author keywords

Beta catenin; Diabetes; GLP 1; Insulin; Pancreatic; Proglucagon; Tcf; Wnt

Indexed keywords

STAT1 PROTEIN; T CELL FACTOR 4; T CELL FACTOR PROTEIN; WNT PROTEIN;

ARTICLE; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY;

COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; GENETIC VARIATION; HUMANS; STAT1 TRANSCRIPTION FACTOR; TCF TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 61349132129     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)00619-5     Document Type: Review

References (49)

1. Ahmed Y., Hayashi S., Levine A., and Wieschaus E. Regulation of Armadillo by a Drosophila APC inhibits neuronal apoptosis during retinal development. Cell 93 (1998) 1171-1182
2. Albuquerque C., Breukel C., van der Luijt R., Fidalgo P., Lage P., Slors F.G.M., Leitao C.N., Fodde R., and Smits R. The just-right signaling model: APC somatic mutations are selected based on a special level of activation of the beta-catenin signaling cascade. Hum. Mol. Genet 11 (2002) 1549-1560
3. Bienz M. TCF: Transcriptional activator or repressor?. Curr. Opin. Cell Biol 10 (1998) 366-372
4. Bonora E. Protection of pancreatic beta-cells: Is it feasible?. Nutr. Metab. Cardiovasc. Dis 18 (2008) 74-83
5. Bordonaro M., Lazarova D.L., and Sartorelli A.C. The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. Exp. Cell Res 313 (2007) 1652-1666
6. Cauchi S., and Froguel P. TCF7L2 genetic defect and type 2 diabetes. Curr. Diab. Rep 8 (2008) 149-155
7. Cauchi S., El Achhab Y., Choquet H., Dina C., Krempler F., Weigasser R., Nejjari C., Patsch W., Chikri M., Meyre D., and Froguel P. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: A global meta-analysis. J. Mol. Med 8 (2007) 777-782
8. Cavallo R.A., Cox R.T., Moline M.M., Roose J., Polevoy G.A., Clevers H., Peifer M., and Bejsovec A. Drosophila Tcf and Groucho interact to repress wingless signalling activity. Nature 395 (1998) 604-608
9. Chen G., Fernandez J., Mische S., and Courey A.J. A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. Genes Dev 13 (1999) 2218-2230
10. Cook D., Fry M., Hughes K., Sumathipala R., Woodgett J., and Dale T. Wingless inactivates glycogen synthase kinase-3 via an intracellular signaling pathway which involves a protein kinase C. Embo J 15 (1996) 4526-4536
11. Dube P.E., Rowland K.J., and Brubaker P.L. Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: Role of insulin-like growth factor-I. Endocrinology 149 (2008) 291-301
12. Duggirala R., Blangero J., Almasy L., Dyer T.D., Williams K.L., Leach R.J., O'Connell P., and Stern M.P. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am. J. Hum. Genet 64 (1999) 1127-1140
13. Duval A., Busson-Leconiat M., Berger R., and Hamelin R. Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3. Cytogenet. Cell Genet 88 (2000) 264-265
14. Goodarzi M.O., and Rotter J.I. Testing the gene or testing a variant? The case of TCF7L2. Diabetes 56 (2007) 2417-2419
15. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helga son A., Stefansson H., Emilsson V., Helgadottir A., Styrkarsdottir U., Magnusson K.P., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet 38 (2006) 320-323
16. Groden J., Joslyn G., Samowitz W., Jones D., Bhattacharyya N., Spirio L., Thliveris A., Robertson M., Egan S., Meuth M., and White R. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res 55 (1995) 1531-1539
17. Gustafson B., and Smith U. WNT signaling is both an inducer and effector of glucagons-like-peptide-1. Diabetologia 10 (2008) 1768-1770
18. Hammarstedt A., Isakson P., Gustafson B., and Smith U. Wnt-signaling is maintained and adipogenesis inhibited by TNFα but not MCP-1 and resistin. Biochem. Biophys. Res. Comm 357 (2007) 700-706
19. Hasegawa S., Sato T., Akazawa H., Okada H., Maeno A., Ito M., Sugitani Y., Shibata H., Miyazaki J., Katsuki M., Yamauchi Y., Yamamura Ki.K., et al. Apoptosis in neural crest cells by functional loss of APC tumor suppressor gene. Proc. Natl. Acad. Sci. USA 99 (2002) 297-302
20. Helgason A., Palsson S., Thorleifsson G., Grant S.F., Emilsson V., Gunnarsdottir S., Adeyemo A., Chen Y., Chen G., Reynisdottir I., Benediktsson R., Hinney A., et al. Refining the impact of TCF7L2 variants on type 2 diabetes and adaptive evolution. Nat. Genet 39 (2007) 218-222
21. Jin T. Why diabetes patients are more prone to the development of colon cancer. Med. Hypotheses 71 (2008) 241-244
22. Jin T., and Liu L. The Wnt signaling pathway effector TCF7L2 and type II diabetes mellitus. Mol. Endocrinol (2008) Epub ahead of print
23. Kazazawa A., Tsukada S., Kamiyama M., Yanagimoto T., Nakajima M., and Maeda S. Wnt5b partially inhibits canonical Wnt/β-catenin signaling pathway and promotes adipogenesis in 3Y3-L1 preadipocytes. Biochem. Biophys. Res. Commun 330 (2005) 505-510
24. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
25. Kolligs F.T., Hu G., Dang C.V., and Fearon E.R. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol 19 (1999) 5696-5706
26. -/- colon carcinoma. Science 275 (1997) 1784-1787
27. Lazarova D.L., Bordonaro M., Carbone R., and Sartorelli A.C. Linear relationship between WNT activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Int. J. Cancer 11 (2004) 523-531
28. Liu Z., and Habener J.F. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta-cell proliferation. J. Biol. Chem 283 (2008) 8723-8735
29. Loder M.K., Xavier Gda S., McDonald A., and Rutter G.A. TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells. Biochem. Soc. Trans 36 (2008) 357-359
30. Lyssenko V., Lupi R., Marchetti P., Del Guerra S., Orho-Melander M., Aimgren P., Sjogren M., Ling C., Eriksson K.F., Lethagen A.L., Mancarella R., Berglund G., et al. Mechanisms by which common variants in the TCF7L2 gene increases risk of type 2 diabetes. J. Clin. Invest 117 (2007) 2155-2163
31. Morin P.J., Vogelstein B., and Kinzler K.W. Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA 93 (1996) 7950-7954
32. Ni Z., Anini Y., Fang X., Mills G., Brubaker P.L., and Jin T. Transcriptional activation of the proglucagon gene by lithium and beta-catenin in intestinal endocrine L cells. J. Biol. Chem 278 (2003) 1380-1387
33. Orford K., Orford C.C., and Byers S.W. Exogenous expression of β-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J. Cell Biol 14 (1999) 855-868
34. Reynisdottir I., Thorleifsson G., Benediktsson R., Sigurdsson G., Emilsson V., Einarsdottir A.S., Hjorleifsdottir E.E., Orlygsdottir G.T., Bjornsdottir G.T., Saemundsdottir J., Halldorsson S., Hrafnkelsdottir S., et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am. J. Hum. Genet 73 (2003) 323-335
35. Romagnolo B., Berrebi D., Saadi-Keddoucci S., Porteu A., Pichard A.-I., Peuchmaur M., Vandewalle A., Kahn A., and Perret C. Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Cancer Res 59 (1999) 3875-3879
36. Roose J., and Clevers H. Tcf transcription factors: Molecular switches in carcinogenesis. Biochim. Biophys. Acta 87456 (1999) M23-M27
37. Rulifson I.C., Karnik S.K., Heiser P.W., ten Berge D., Chen H., Gu X., Taketo M.M., Nusse R., Hebrok M., and Kim S.K. Wnt signaling regulates pancreatic beta cell proliferation. Proc. Natl. Acad. Sci. USA 104 (2007) 6247-6252
38. Salpea K.D., Gable D.R., Cooper J.A., Stephens J.W., Hurel S.J., Ireland H.A., Feher M.D., Godsland I.F., and Humphries S.E. The effect of WNT5B IVS3C>G on the susceptibility to type 2 diabetes in UK caucasian subjects. Nutr. Metab. Cardiovasc. Dis (2008) Epub ahead of print
39. Schafer S.A., Tschritter O., Machicao F., Thamer C., Stefan N., Gallwitz B., Holst J.J., Dekker J.M.T., Hart L.M., Nijpels G., van Haeften T.W., Haring H.U., et al. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like2 (TCF7L2) gene polymorphisms. Diabetologia 50 (2007) 2443-2450
40. Shu L., Sauter N.S., Schulthess F.T., Matveyenko A.V., Oberholzer J., and Maedler K. Transcription factor 7-like2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 57 (2008) 645-653
41. Stambolic V., Ruel L., and Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol 6 (1996) 1664-1668
42. Su L.-K., Vogelstein B., and Kinzler K.W. Association of the APC tumor suppresser protein with catenins. Science 262 (1993) 1734-1737
43. Valenta T., Lukas J., and Korinek V. HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target axin2/conductin in human embryonic kidney cells. Nucleic Acids Res 31 (2003) 2369-2380
44. Wong M.H., Huelsken J., Birchmeier W., and Gordon J.I. Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkühn is perturbed by β-catenin signaling. J. Biol. Chem 277 (2002) 15843-15850
45. Woodgett J. Regulation and functions of the glycogen synthase kinase-3 subfamily. Semin. Cancer Biol 5 (1994) 269-275
46. Yi F., Brubaker P.L., and Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by β-catenin and glycogen synthase kinase-3β. J. Biol. Chem 280 (2005) 1457-1464
47. Yi F., Sun J., Lim G.E., Fantus I.G., Brubaker P.L., and Jin T. Crosstalk between the insulin and Wnt signaling pathways: Evidence from intestinal endocrine cells. Endocrinology 149 (2008) 2341-2352
48. Zhang T., Otevrel T., Gao Z., Ehrlich S.M., Fields J.Z., and Boman B.M. Evidence that APC regulates survivin expression: A possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61 (2001) 8664-8667
49. Zimmet P., Alberti K.G.M.M., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787